A Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different Treatments

计划入组 135 人 · 首次发布于 2012 年 2 月 8 日

Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1)

计划入组 768 人 · 首次发布于 2014 年 5 月 29 日

Treatment of Myelodysplastic Syndromes Comparing Hydralazine/Ac. Valproic and Supportive Care in Patients Not Candidates, Refractory and/or Intolerant to Intensive Chemotherapy

计划入组 42 人 · 首次发布于 2011 年 5 月 20 日

BSC-1020

BSC-1401

BSC-1201

4SC AG

Germany

CENEXI HSC

France

BOC LIMITED

United Kingdom

Keytruda Demonstrates Overall Survival Benefit in Advanced Hepatocellular Carcinoma

Avelumab Maintenance Shows Consistent Survival Benefits in Advanced Urothelial Cancer Patients With and Without Diabetes

Fruquintinib Approved in Japan for Previously Treated Metastatic Colorectal Cancer